Le Lézard
Classified in: Health, Covid-19 virus
Subject: IMA

BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia


SHENZHEN, China, Nov. 3, 2021 /PRNewswire/ -- As reported by Indonesian National Agency of Drug and Food Control (BPOM), BPOM grants the Emergency Use Authorization (EUA) for COVID-19 Vaccine (ChAdOx1-S[recombinant])/KconecaVac manufactured by Shenzhen Kangtai Biological Products Co., Ltd. It is understood that this is China's second adenovirus vector COVID-19 vaccine approved for emergency use overseas.

BPOM source: https://cekbpom.pom.go.id//home/produk/ia50q76n48d7ou9ibfgcn3rik7/all/row/10/page/1/order/4/DESC/search/0/EUA

SOURCE Shenzhen Kangtai Biological Products Co.,Ltd.


These press releases may also interest you

at 02:15
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:00
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

9 mai 2024
Star Asia Group to Acquire 100% of Minacia Co. Ltd, a Leading Domestic Hotel Operator
Star Asia Group is pleased to announce that it has entered into a share transfer agreement with Minacia Co., Ltd. ("Minacia") on April 26, 2024, to acquire 100% of the shares of Minacia. 1? Reason for Share Acquisition Star Asia Group believes that...

9 mai 2024
CORRECTION - Doman Building Materials Group Ltd. Announces First Quarter 2024 Financial Results
In the Company's announcement dated May 9, 2024, the 2023 comparative year EBITDA was corrected from $33.2 million to $44.8 million. The complete correct press release follows: Q1 2024 Financial Highlights(1): Revenues of $602.5 millionGross Margin...

9 mai 2024
Afya Limited Announces First-Quarter 2024 Financial Results
Afya Limited ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024)....

9 mai 2024
Source Energy Services Reports Q1 2024 Results
Source Energy Services Ltd. ("Source" or the "Company") is pleased to announce its financial results for the three months ended March 31, 2024. Q1 2024 PERFORMANCE HIGHLIGHTS Key achievements for the quarter ended March 31, 2024 include the...

More news about Covid-19 virus...


News published on and distributed by: